References
- Lund Hiheim L, Home I, Hjermann I, et al. Trends in the incidence of acute myocardial infarction and stroke: A 21-year follow-up of the Oslo-study. Scand Cardiovasc J 2004; 38: 000–000.
- Strandberg TE, Salomaa VV, Vanhanen HT, Naukkarinen VA, Sama S, Miettmen TA. Mortality in participants and non-participants of a multifactonal prevention study of cardiovascular disease: A 28 year follow-up of the Helsinki Businessmen Study. Br Heart J 1995; 74: 449–454.
- Abildstrom SZ, Rasmussen S, Madsen M Significant decline in case fatality after acute myocardial infarction in Denmark — A population-based study from 1994 to 200L Scand Cardiovasc J 2002; 36: 287-29L
- Salomaa V. Miettinen H, Kuulasmaa K, et al. Decline of coronary heart disease mortality in Finland during 1983 to 1992: Roles of incidence, recurrence and case-fatality. The FINMONICA MI Register Study. Circulation 1996; 94: 3130–3137.
- Women's Ischemic Syndrome Evaluation. Current status and future research directions. Report of the National Heart, Lung and Blood Institute Workshop, October 2-4,2002 Executive Summary. Circulation 2004; 109: 805–807.
- Hetemaa T, Keskimäki I, Salomaa V. et al. Socioeconomic inequities in invasive cardiac procedures after first myocardial infarction in Finland in 1995. J Clin Epidemiol 2004; 57: 301–308.
- Kjeldsen SE, Julius S, Hedner T, Hansson L. Stroke is more common than myocardial infarction in hypertension: Analysis based on 11 major randomized intervention trials. Blood Pressure 2001; 10: 190–192.
- Salomaa V. Ketonen M, Koukkunen H, et al. Decline in out-of-hospital coronary heart disease deaths has contributed the main part to the overall decline in coronary disease mortality rates among persons 35 to 64 years of age in Finland: The FINAMI study. Circulation 2003; 108: 691–696.
- Salomaa V. Ketonen M, Koukkunen H, et al. Trends in coronary events in Finland during 1983-1997. The Finami study. Eur Heart J 2003; 24: 311–319.
- Vartiainen E, Puska P. Pekkanen J, Tuomilehto J, Jousilahti P. Changes in risk factors explain changes in mortality from ischaemic heart disease in Finland. BMJ 1994; 304: 23–27.
- Capewell S, Pell JP, Morrison CA, McMurray JJ. Contribution of modem cardiovascular treatment and risk factor changes to the decline in coronary heart disease mortality in Scotland between 1975 and 1994. Heart 1999; 81: 360–386.
- Law MR, Wald NJ, Rudnicka AR. Quantifying effects of statin on low density lipoprotein cholesterol, ischeamic heart disease, and stroke: Systematic review and meta-analysis. BMJ 2003; 326: 1407–1408.
- Greenland P, Knoll MD, Stamler J, et al. Major risk factors as antecedents of fatal and nonfatal coronary heart disease events. JAMA 2003; 290: 891–897.
- Khot UN, Khot MB, Bajzer CT, et al. Prevalence of conventional risk factors in patients with coronary heart disease. JAMA 2002; 290: 898–904.
- Executive summary. European guidelines on cardiovascular disease prevention in clinical practice.Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J 2003; 24: 1601–1610.
- Clinical reality in coronary prevention guidelines: A comparison of EURO-ASPIRE land II in nine countries. EUROASPIRE land II Group. Lancet 2011; 357: 995–1001.